Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AF Direct factor Xa inhibitors
B01AF03 Edoxaban
D09546 Edoxaban tosilate hydrate (JAN) <JP/US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Anticoagulants
Factor Xa Inhibitors, Direct
Edoxaban
D09546 Edoxaban tosilate hydrate (JAN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
333 Anticoagulants
3339 Others
D09546 Edoxaban tosilate hydrate (JAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01662 Factor Xa inhibitor
DG01398 Edoxaban
D09546 Edoxaban tosilate hydrate
DG03320 Direct oral anticoagulant (DOAC)
DG01398 Edoxaban
D09546 Edoxaban tosilate hydrate
Transporter substrate
DG01665 ABCB1 substrate
DG01398 Edoxaban
D09546 Edoxaban tosilate hydrate
Drug classes [BR:br08332]
Anticoagulant
DG03320 Direct oral anticoagulant (DOAC)
D09546 Edoxaban tosilate hydrate
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Chymotrypsin family
F10
D09546 Edoxaban tosilate hydrate (JAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09546
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09546
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09546
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09546
Drug metabolizing enzymes and transporters [br08309.html]
Drug transporters
D09546
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01662 Factor Xa inhibitor
DG01398 Edoxaban
DG03320 Direct oral anticoagulant (DOAC)
DG01398 Edoxaban
Transporter substrate
DG01665 ABCB1 substrate
DG01398 Edoxaban